Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling.
about
Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression.The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma modelsThe contributions of HIF-target genes to tumor growth in RCC.Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer.High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma.Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell CarcinomaCox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.Ovatodiolide Targets β -Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma.Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma.Temsirolimus: a safety and efficacy review.2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β Activation.Characterization of mechanism involved in acquired resistance to sorafenib in a mouse renal cell cancer RenCa model.Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.Nuclear magnetic resonance imaging of tumour growth and neovasculature performance in vivo reveals Grb7 as a novel antiangiogenic target.Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma.Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity.The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy.Sunitinib resistance in renal cell carcinoma.The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma.Characterisation of the Morphological, Functional and Molecular Changes in Sunitinib-Resistant Renal Cell Carcinoma Cells
P2860
Q33895119-04A108A0-35BD-4527-A6D4-048636C9D906Q33912405-54E2D1F6-872F-4B19-BE48-28A918EED6AAQ34077272-FC4295B9-B2FD-44F6-BBB3-82F8FED51542Q34978329-8635C2AD-7AE9-4C0E-ADB2-97813D7D9F20Q35049084-C1CA2410-A6C8-4A8C-AE52-F7784234BD0FQ35568516-D7BD2689-59F9-4236-A216-13FA1761F72FQ35672426-476B2DCE-B444-496D-8A02-397454714036Q35675548-C0147E0A-2DB0-429D-85D8-4D58C44BCAEDQ36594073-FD4901A2-8124-4209-8E1B-60F76C490B32Q36916021-50C11755-68B5-456D-BAD0-2813F5AF56B7Q37520379-568BBA72-49D0-49C0-9A6F-7ED360849A7FQ38031941-BD93A4DB-A524-4E39-8CC9-072B95C78BCBQ38324927-A93674BF-59DE-487D-B877-0E8CDDD9E924Q39041660-F5FEC141-041C-4ACD-BEAB-CE3BA034AA01Q39146399-D25DC7DF-AD5B-4C90-83C5-0BBBFC2B037DQ39205018-9059632B-1B6C-4950-ACA3-DFA91E7D1747Q39213121-376957AF-20E0-4522-88A1-922563BC9CD7Q39383527-2438A03C-910E-4DC9-9F38-C4FF418680BBQ41869709-6E718910-3512-41A3-AC21-65622FAE0DD3Q44456046-B1DE061C-5BB3-4DA3-8954-9A76BC38B15BQ51763292-E271953F-B71B-4007-8448-B1BA7152D495Q52728099-FA75B949-4941-4389-B5E6-DE293B0466C0Q58790703-E4B95DA7-98C2-4147-9248-48FAEDEA7290
P2860
Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@ast
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@en
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@nl
type
label
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@ast
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@en
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@nl
prefLabel
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@ast
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@en
Renal cancer resistance to ant ...... tion of angiostatic signaling.
@nl
P2093
P2860
P1476
Renal cancer resistance to ant ...... ation of angiostatic signaling
@en
P2093
James W Mier
Liang Zhang
Michael B Atkins
Michael P Collins
Rupal S Bhatt
S Nahum Goldberg
Sabina Signoretti
Xiaoen Wang
P2860
P304
P356
10.1158/1535-7163.MCT-10-0477
P50
P577
2010-08-10T00:00:00Z